Balchem Corporation (NASDAQ:BCPC) Shares Sold by Stephens Investment Management Group LLC

Stephens Investment Management Group LLC lessened its stake in shares of Balchem Corporation (NASDAQ:BCPC - Free Report) by 1.2% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 275,687 shares of the basic materials company's stock after selling 3,240 shares during the quarter. Stephens Investment Management Group LLC owned about 0.85% of Balchem worth $45,764,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently made changes to their positions in the company. SG Americas Securities LLC purchased a new position in shares of Balchem in the first quarter worth approximately $1,148,000. GAMMA Investing LLC boosted its holdings in shares of Balchem by 22.5% in the first quarter. GAMMA Investing LLC now owns 1,068 shares of the basic materials company's stock worth $177,000 after buying an additional 196 shares during the last quarter. Cambridge Investment Research Advisors Inc. boosted its holdings in shares of Balchem by 243.2% in the first quarter. Cambridge Investment Research Advisors Inc. now owns 9,390 shares of the basic materials company's stock worth $1,559,000 after buying an additional 6,654 shares during the last quarter. Sowell Financial Services LLC purchased a new position in shares of Balchem in the first quarter worth approximately $202,000. Finally, KBC Group NV boosted its holdings in shares of Balchem by 24.1% in the first quarter. KBC Group NV now owns 1,582 shares of the basic materials company's stock worth $263,000 after buying an additional 307 shares during the last quarter. Hedge funds and other institutional investors own 87.91% of the company's stock.

Analyst Ratings Changes

BCPC has been the topic of a number of recent analyst reports. HC Wainwright set a $180.00 target price on shares of Balchem and gave the stock a "buy" rating in a research note on Monday, April 28th. Wall Street Zen cut shares of Balchem from a "buy" rating to a "hold" rating in a research note on Wednesday, May 21st.

Balchem Price Performance

BCPC traded up $0.64 during trading hours on Wednesday, hitting $158.14. The company's stock had a trading volume of 153,258 shares, compared to its average volume of 143,035. The business's 50-day moving average price is $163.50 and its 200-day moving average price is $162.76. Balchem Corporation has a 12 month low of $145.70 and a 12 month high of $186.03. The stock has a market cap of $5.16 billion, a price-to-earnings ratio of 37.92, a P/E/G ratio of 3.40 and a beta of 0.89. The company has a current ratio of 2.44, a quick ratio of 1.40 and a debt-to-equity ratio of 0.18.

Balchem (NASDAQ:BCPC - Get Free Report) last posted its quarterly earnings data on Thursday, April 24th. The basic materials company reported $1.22 EPS for the quarter, missing the consensus estimate of $1.25 by ($0.03). The firm had revenue of $250.52 million for the quarter, compared to analysts' expectations of $245.70 million. Balchem had a return on equity of 12.01% and a net margin of 14.16%. The firm's quarterly revenue was up 4.5% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.03 earnings per share. Sell-side analysts expect that Balchem Corporation will post 4.64 earnings per share for the current fiscal year.

About Balchem

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.